國統局:2月一線城市新住房及二手住房售價按年升4.4%及3.5%
國家統計局城市司首席統計師繩國慶解讀2022年2月份商品住宅銷售價格變動情況統計數據時表示,2月份,70個大中城市中,新建商品住宅和二手住宅銷售價格按年上漲城市分別有46個和30個,按年下降城市分別有24個和39個。
2月份,一線城市新建商品住宅銷售價格按年上漲4.4%,漲幅與上月相同;二手住宅按年上漲3.5%,漲幅比上月回落0.6個百分點。
二線城市新建商品住宅和二手住宅銷售價格按年分別上漲2.1%和0.3%,漲幅比上月分別回落0.4和0.7個百分點。
三線城市新建商品住宅銷售價格按年由上月上漲0.5%轉爲下降0.1%;二手住宅按年下降1.3%,降幅比上月擴大0.6個百分點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.